发明名称 |
Dosage form to increase prasterone bioavailability |
摘要 |
A way to formulate prasterone to both increase its oral bioavailability, and decrease the variability of its oral bioavailability.;
In contrast to the approach taught by the prior art, the instant approach is amenable to scale-up to commercial scale. Further, the resulting product is amenable to analysis using standard, known quantitative analytical techniques; thus, unlike the prior art approach, the instant approach may be used to manufacture a product in conformity with applicable regulatory standards. |
申请公布号 |
US8900631(B2) |
申请公布日期 |
2014.12.02 |
申请号 |
US201213453987 |
申请日期 |
2012.04.23 |
申请人 |
Health Science Funding, LLC |
发明人 |
Pohl J. Mark |
分类号 |
A61K9/48;A61K31/5685;C07J1/00;A61K9/14 |
主分类号 |
A61K9/48 |
代理机构 |
Pharmaceutical Patent Attorneys, LLC |
代理人 |
Pharmaceutical Patent Attorneys, LLC |
主权项 |
1. A soft gelatin capsule suitable for oral administration, said soft gelatin capsule comprising:
A. a soft gelatin capsule, and B. a fill,
i. said fill consisting essentially of a durable oil vehicle, andii. at least about 100 milligrams of prasterone, and C. said soft gelatin capsule further having an outer lubricant coating. |
地址 |
Morristown NJ US |